Patients on Synjardy can deveop several life-threatening side effects involving too much acid in the bloodstream. The FDA has issued warnings about diabetic ketoacidosis (DKA). The label on Synjardy also has a “Black Box” warning about lactic acidosis.
What You Can Do & How We Can Help
The Schmidt Firm, PLLC is currently accepting Synjardy induced injury cases in all 50 states. If you or somebody you know has been diagnosed with a severe side effect, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Synjardy and Ketoacidosis
Synjardy contains empagliflozin and metformin. These ingredients help control blood-sugar levels in different ways, but they can both lead to life-threatening side effects involving too much acid in the blood.
The Prescribing Information (PDF) for Synjardy includes a “Black Box” warning about lactic acidosis, a condition that occurs when cells are not getting enough oxygen.
In December 2015, the FDA issued a Safety Communication for Synjardy to warn about diabetic ketoacidosis (DKA), a condition in which high levels of toxins called ketones cause the blood to become too acidic.
What Should I Do?
Ketoacidosis occurs when the body does not have enough insulin to use blood-sugar for energy, so it starts burning fat instead. When the body metabolizes fats, acidic wastes called ketones are released by the liver.
Ketoacidosis causes frequent urination, which depletes minerals like potassium and salts. In less than 24 hours, serious imbalances in blood-chemistry and electrolytes can cause serious symptoms.
Patients on Synjardy can use a dipstick test to check urine for ketones. Blood-sugar levels may be normal or only slightly increased, which can delay diagnosis and treatment. The FDA recommends seeking emergency medical attention for the following symptoms of ketoacidosis:
- Difficulty breathing
- Nausea
- Vomiting
- Abdominal pain
- Confusion
- Unusual fatigue or sleepiness
Individual Lawsuits May Be Centralized in MDL
Several people who developed ketoacidosis after using diabetes drugs in the SGLT2 inhibitor class have already filed lawsuits. In the future, federal judges may create a “mass-tort” or Multi-District Litigation (MDL) to centralize individual Synjardy lawsuits. This has many of the advantages of a class action, but each case remains independent.
What is the problem?
The Schmidt Firm, PLLC is nationally recognized as a class action law firm. However, our trial lawyers are not pursuing justice for our clients through a Synjardy class action. Instead, we are filing individual lawsuits involving people who were injured by severe side effects, such as:
- Diabetic ketoacidosis
- Kidney infections
- Kidney failure
- Urinary tract infections
- Pyelonephritis
- Urosepsis
About Class Actions
The advantage of a class action is that a lot of people with similar legal claims can join together and collectively seek compensation. Any compensation awarded by a lawsuit verdict or settlement is divided equally among everyone in the class action.
Why Our Law Firm is Filing Individual Lawsuits as Opposed to a Class Action
Class actions are an efficient way to resolve a lot of lawsuits, but they are not designed to maximize compensation for people with severe injuries. Members may have to accept a “low-ball” settlement or attorneys’ fees that do not leave much remaining for everyone in the lawsuit.
Instead of a class action, our lawyers are filing individual lawsuits. We specialize in helping victims of defective drugs seek justice from pharmaceutical companies that fail to warn about side effects. If you decide to join this litigation, you could receive compensation for your pain and suffering, medical expenses, lost income, and more.
Do I have a Synjardy Lawsuit?
The Schmidt Firm, PLLC is currently accepting Synjardy induced injury cases in all 50 states. If you or somebody you know has been diagnosed with ketoacidosis, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.